We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+6.87%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$2.44B
AUM Growth
+$158M
Cap. Flow
+$19.9M
Cap. Flow %
0.81%
Top 10 Hldgs %
18.86%
Holding
1,327
New
132
Increased
670
Reduced
388
Closed
91
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MVF
1176
DELISTED
BlackRock MuniVest Fund
MVF
$99K ﹤0.01%
11,085
-9,295
-46% -$84.8K
AWP
1177
abrdn Global Premier Properties Fund
AWP
$363M
$98K ﹤0.01%
4,554
+260
+6% +$5.61K
MFA
1178
MFA Financial
MFA
$919M
$94K ﹤0.01%
3,342
+70
+2% +$2.05K
HCBK
1179
DELISTED
HUDSON CITY BANCORP INC
HCBK
$94K ﹤0.01%
10,014
-393
-4% -$3.6K
RSO
1180
DELISTED
Resource Capital Corp.
RSO
$93K ﹤0.01%
3,907
-76
-2% -$1.81K
MCR
1181
DELISTED
MFS Charter Income Trust
MCR
$91K ﹤0.01%
10,021
-481
-5% -$4.31K
MFM
1182
Aberdeen Municipal Income Fund
MFM
$222M
$90K ﹤0.01%
14,368
+3,650
+34% +$22.6K
OIA icon
1183
Invesco Municipal Income Opportunities Trust
OIA
$290M
$90K ﹤0.01%
14,550
+2,580
+22% +$15.9K
MHY
1184
DELISTED
WESTERN ASSET MANAGED HIGH INCOM FD INC. COM
MHY
$90K ﹤0.01%
15,951
+4,992
+46% +$28.3K
SSRI
1185
DELISTED
Silver Standard Resources
SSRI
$87K ﹤0.01%
12,539
+1,315
+12% +$7.95K
USA icon
1186
Liberty All-Star Equity Fund
USA
$1.86B
$84K ﹤0.01%
14,095
ACGN
1187
DELISTED
Aceragen Inc
ACGN
$83K ﹤0.01%
+132
New +$44K
SCLN
1188
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
$82K ﹤0.01%
16,175
-704
-4% -$3.39K
CLM icon
1189
Cornerstone Strategic Value Fund
CLM
$2.24B
$81K ﹤0.01%
+3,124
New +$85.2K
OPCH icon
1190
Option Care Health
OPCH
$3.67B
$81K ﹤0.01%
+2,725
New +$77K
MCP
1191
DELISTED
MOLYCORP INC COM STK
MCP
$79K ﹤0.01%
14,030
-546
-4% -$2.88K
XCO
1192
DELISTED
Exco Resources
XCO
$76K ﹤0.01%
952
+87
+10% +$7.42K
MHF
1193
Western Asset Municipal High Income Fund
MHF
$153M
$75K ﹤0.01%
11,100
ATAXZ
1194
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
$75K ﹤0.01%
+11,874
New +$75K
MIN
1195
Aberdeen Intermediate Income Fund
MIN
$278M
$73K ﹤0.01%
14,020
-4,250
-23% -$22.1K
CRF
1196
Cornerstone Total Return Fund
CRF
$1.17B
$70K ﹤0.01%
+2,933
New +$72.7K
ARR
1197
Armour Residential REIT
ARR
$2.34B
$69K ﹤0.01%
430
-57
-12% -$9.18K
UNIS
1198
DELISTED
Unilife Corporation
UNIS
$68K ﹤0.01%
+1,549
New +$56.7K
AUQ
1199
DELISTED
AURICO GOLD INC COM
AUQ
$67K ﹤0.01%
18,422
+2,798
+18% +$10.8K
EMKR
1200
DELISTED
Emcore Corp
EMKR
$65K ﹤0.01%
1,260

Similar funds

Cambridge Investment Research Advisors's Q4 2013 Portfolio in Review

As of Q4 2013, Cambridge Investment Research Advisors held 1,327 positions worth $2.44B, up 6.9% from $2.28B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Cambridge Investment Research Advisors's Q4 2013 filing shows 132 new, 670 increased, 388 reduced and 91 closed positions. Its largest new stake was Walt Disney: 66,609 shares worth $5.09M. The largest sale was Vanguard S&P 500 ETF, an estimated $54.2M.

By sector, the portfolio is most concentrated in Energy at 6.4% of assets, up from 6.1% a quarter earlier, followed by Financials and Healthcare.

  • Cambridge Investment Research Advisors's largest Q4 2013 buy was Walt Disney: 66,609 shares worth $5.09M.
  • Cambridge Investment Research Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2013, an estimated $29.3M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2013 reduction was Kayne Anderson Energy Infrastructure Fund, cutting an estimated $16.5M.
  • Cambridge Investment Research Advisors fully exited Vanguard S&P 500 ETF in Q4 2013, selling an estimated $54.2M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 19% of its $2.44B portfolio in Q4 2013.
  • Cambridge Investment Research Advisors opened 132 new positions and closed 91 in Q4 2013.
  • Cambridge Investment Research Advisors's portfolio value rose 6.9% quarter-over-quarter to $2.44B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2013, filed 24 Jan 2014.